(Q40836544)

24 September 2017

1 reference

title

Consensus review of the clinical utility of DNA content cytometry in prostate cancer (English)

1 reference

24 September 2017

author

Olli-Pekka Kallioniemi

2

1 reference

24 September 2017

Shankey TV

1

1 reference

24 September 2017

Koslowski JM

3

1 reference

24 September 2017

Lieber ML

4

1 reference

24 September 2017

Mayall BH

5

1 reference

24 September 2017

Miller G

6

1 reference

24 September 2017

Smith GJ

7

1 reference

24 September 2017

publication date

1 January 1993

1 reference

24 September 2017

number of pages

4

1 reference

inferred from page(s)

published in

Cytometry

1 reference

24 September 2017

volume

14

1 reference

24 September 2017

issue

5

1 reference

24 September 2017

page(s)

497-500

1 reference

Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas: implications for prognosis and response to endocrine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

Early detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

The prognostic value of modal deoxyribonucleic acid in low grade, low stage untreated prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

Evaluation of tumor progression by repeated fine needle biopsies in prostate adenocarcinoma: modal deoxyribonucleic acid value and cytological differentiation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

Nuclear DNA analysis: the relevance of ploidy, DNA heterogeneity and phases of the cell cycle in 329 patients with prostatic carcinoma. A study on a follow-up of eight years

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

DNA ploidy, S phase fraction and G2 fraction as prognostic determinants in prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

Prostatic carcinoma cell DNA content measured by flow cytometry and its relation to clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

The prognostic significance of nuclear DNA content in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

DNA-ploidy as prognostic factor in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

Histologic Grade, DNA Ploidy, and Intraglandular Tumor Extent as Indicators of Tumor Progression of Clinical Stage B Prostatic Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

The prognostic value of deoxyribonucleic acid flow cytometric analysis in stage D2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

Prediction of prognosis in untreated stage A2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

Modal DNA values and estramustine-binding protein (EMBP) as prognostic markers in prostatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

Radical prostatectomy after radiation therapy for cancer of the prostate: feasibility and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

Relationship of DNA content to conventional prognostic factors in clinically localised carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

Correlation between ploidy and prognosis in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

DNA flow cytometry in carcinoma of the prostate for diagnosis, prognosis and study of tumor biology

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

Flow Cytometric DNA Analysis of Stage D2 Prostatic Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

Ploidy level and tumor progression in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

Deoxyribonucleic Acid Ploidy and the Direct Assay of Prostatic Acid Phosphatase and Prostate Specific Antigen in Fine Needle Aspiration Biopsies as Diagnostic Methods in Prostatic Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

Guidelines for implementation of clinical DNA cytometry. International Society for Analytical Cytology.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140508

7 January 2021

Identifiers

DOI

10.1002/CYTO.990140508

1 reference

24 September 2017

1 reference